Lotus Pharmaceuticals Inc (LTUS)

Lotus Pharmaceuticals Inc. is a common stock listing on OTC Markets in the healthcare sector. The company reports no significant current operations. In the past, it was involved in pharmaceutical development, manufacturing, and sales in China. The issuer was formerly known as S.E. Asia Trading, Inc. and adopted the Lotus Pharmaceuticals, Inc. name in December 2006. The company is based in Irvine, California.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-LTUS
Not available
Not available
Not available
Great
0.0%
10.71 M
Valuation • Fair Value

Lotus Pharmaceuticals Inc (OTC-LTUS) Fair Value by Valuation Model

No usable valuation estimate is currently available for Lotus Pharmaceuticals Inc (OTC-LTUS); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Lotus Pharmaceuticals Inc (OTC-LTUS). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Lotus Pharmaceuticals Inc (OTC-LTUS)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Lotus Pharmaceuticals Inc (OTC-LTUS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Lotus Pharmaceuticals Inc (OTC-LTUS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Lotus Pharmaceuticals Inc (OTC-LTUS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Lotus Pharmaceuticals Inc (OTC-LTUS)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Lotus Pharmaceuticals Inc (OTC-LTUS). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Lotus Pharmaceuticals Inc (OTC-LTUS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Lotus Pharmaceuticals Inc (OTC-LTUS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Lotus Pharmaceuticals Inc (OTC-LTUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Lotus Pharmaceuticals Inc (OTC-LTUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Lotus Pharmaceuticals Inc (OTC-LTUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Lotus Pharmaceuticals Inc (OTC-LTUS) Stock FAQ

Data-supported answers about Lotus Pharmaceuticals Inc (OTC-LTUS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Great
Current financial-health read

A reliable fair value estimate is not currently available for Lotus Pharmaceuticals Inc (OTC-LTUS). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Lotus Pharmaceuticals Inc (OTC-LTUS) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Lotus Pharmaceuticals Inc (OTC-LTUS).

The current market capitalization listed for Lotus Pharmaceuticals Inc is 10.71 M.

The ticker symbol for Lotus Pharmaceuticals Inc is OTC-LTUS, and the stock is listed on OTC Markets.

Lotus Pharmaceuticals Inc (OTC-LTUS) is listed on OTC Markets.